▎ VIAL TRUST REPORTLast evaluated July 8, 2026
Direct Peptides
VIAL · DIRECT PEPTIDES · GREY MARKET VENDOR
TYPEHQSTATESGrey Market VendorTX50
Vial Score
getvial.com/report/direct-peptides40/100
Confirmed adverse record on fileVial Score over time
54 (May 27) → 40 (Jul 8) · 5 snapshots
Scoring method updated: a Vial change, not a provider change.
COMPOUNDS OFFERED
6 of 6 applicable signals confirmed
We confirmed all 6 checks that apply to this vendor type.
WHAT WE CONFIRMED
- —
WHAT WE COULDN'T VERIFY
- Physician oversight not publicly disclosed
- NPI not confirmed in federal registry
- Pricing not publicly disclosed
- LegitScript certification not confirmed
Where this score differs
How Direct Peptides compares with similar providers Vial tracks.
- Compare →Direct Peptides vs Simple PeptideDirect Peptides scores 40 — compare with Simple Peptide side-by-side
- Compare →Direct Peptides vs Limitless Life NootropicsDirect Peptides scores 40 — compare with Limitless Life Nootropics side-by-side
- Compare →Direct Peptides vs Core PeptidesDirect Peptides scores 40 — compare with Core Peptides side-by-side
Before you pay, ask
Questions to bring to Direct Peptides before committing.
- 01Who is medically responsible for prescribing decisions, and what are their credentials?
- 02What is the all-in cost of the protocol you're recommending?
- 03What documentation can you provide to back the compliance claims on your website?
- 04What happens to my care and prescriptions if I want to discontinue?
Share
WHAT THIS MEANS
This provider's federal NPI registration could not be confirmed. Ask for the prescribing physician's NPI directly.
No FDA enforcement actions are on record for this provider in the public openFDA database.
Some legitimate providers — particularly newer brands and small practices — have minimal public records. This isn't proof of risk, but it does mean trust has to be established directly with the provider rather than via federal databases.
REPORT HISTORY▸ Latest: Jun 1 2026 · Vial scoring enhancement
May 27, 2026
Vial score established · 54/100
May 31, 2026
Score increased 8 pts → 62/100
Jun 01, 2026 · SCORING ENHANCEMENT
Vial scoring enhancement
Scores were recalculated under an evidence-weighted model: a provider's score now reflects how much Vial has verified, so thinly-documented records sit near the neutral baseline instead of reaching the extremes. Lab credentials (CLIA/CAP) were added as positive evidence, a verified-clean US federal record (FDA/OIG/DEA) now counts toward regulatory standing for US-based providers (a clean US screen is not credited to an overseas provider that those registries would never list), every scored dimension holds a consistent neutral baseline where Vial has not yet verified it, and grey-market vendors are flagged. This is a Vial scoring change, not a change at the provider.
WHEN WE LAST CHECKED
FDA2026-06-03
OIG2026-07-06
DEA2026-07-27
HIPAA2026-07-06
NPI2026-07-06
BBB2026-05-27
PCAB2026-06-04
Are you Direct Peptides?
Claim this profile to add disclosures, or dispute findings with documentation.
Want us to watch Direct Peptides for you?
We'll email you if anything changes about this provider:
- A new enforcement action appears
- Their Vial Score moves
- Their pharmacy partner changes
- Complaint patterns emerge
Free. We’ll only email when something actually changes.